| Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways S Baumeister, J Wiesner, A Reichenberg, M Hintz, S Bietz, OS Harb, ... PLoS One 6 (5), e19334, 2011 | 91 | 2011 |
| Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria M Kordes, K Matuschewski, JCR Hafalla Infection and immunity 79 (9), 3633-3641, 2011 | 84 | 2011 |
| Vaccine-Like Immunity against Malaria by Repeated Causal-Prophylactic Treatment of Liver-Stage Plasmodium Parasites ED Putrianti, O Silvie, M Kordes, S Borrmann, K Matuschewski The Journal of infectious diseases 199 (6), 899-903, 2009 | 66 | 2009 |
| Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling M Kordes, M Röring, C Heining, S Braun, B Hutter, D Richter, C Geörg, ... Leukemia 30 (4), 937, 2016 | 59 | 2016 |
| Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer A Khomiak, M Brunner, M Kordes, S Lindblad, RC Miksch, D Öhlund, ... Cancers 12 (11), 3234, 2020 | 51 | 2020 |
| Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis M Vujasinovic, A Dugic, P Maisonneuve, A Aljic, R Berggren, N Panic, ... Journal of Clinical Medicine 9 (11), 3720, 2020 | 49 | 2020 |
| Pancreatic cancer cachexia: three dimensions of a complex syndrome M Kordes, L Larsson, L Engstrand, JM Löhr British Journal of Cancer 124 (10), 1623-1636, 2021 | 47 | 2021 |
| Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer DW Hagey, M Kordes, A Görgens, MO Mowoe, JZ Nordin, CF Moro, ... Journal of extracellular vesicles 10 (12), e12142, 2021 | 28 | 2021 |
| Survival Benefits of Chemotherapy for Patients with Advanced Pancreatic Cancer in A Clinical Real-World Cohort M Kordes, J Yu, O Malgerud, M Gustafsson Liljefors, J Löhr Cancers 11 (9), 1326, 2019 | 25 | 2019 |
| Respect-A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer M Weniger, J Moir, M Damm, L Maggino, M Kordes, J Rosendahl, ... Pancreatology 20 (6), 1131-1138, 2020 | 19 | 2020 |
| Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma J Yu, A Ploner, M Kordes, M Löhr, M Nilsson, MEL de Maturana, ... International Journal of Cancer 148 (8), 2048-2058, 2021 | 13 | 2021 |
| Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial KJ Labori, SO Bratlie, B Andersson, JH Angelsen, C Biörserud, ... The Lancet Gastroenterology & Hepatology 9 (3), 205-217, 2024 | 9 | 2024 |
| Impact of spatio-temporal recurrence pattern on overall survival for invasive intraductal papillary mucinous neoplasia–a comparison with pancreatic ductal adenocarcinoma M Holmberg, S Linder, M Kordes, M Liljefors, P Ghorbani, JM Löhr, ... Pancreatology 22 (5), 598-607, 2022 | 9 | 2022 |
| Variations in the management of diarrhoea induced by cancer therapy: results from an international, cross-sectional survey among European oncologists M Kordes, M Gerling ESMO open 4 (6), e000607, 2019 | 9 | 2019 |
| Neoadjuvant therapy in elderly patients receiving FOLFIRINOX or gemcitabine/nab-paclitaxel for borderline resectable or locally advanced pancreatic cancer is feasible and lead … M Weniger, J Moir, M Damm, L Maggino, M Kordes, J Rosendahl, ... Surgical Oncology 35, 285-297, 2020 | 7 | 2020 |
| Overcoming diagnostic issues in precision treatment of pancreatic cancer JM Löhr, M Kordes, W Rutkowski, R Heuchel, M Gustafsson-Liljefors, ... Expert Review of Precision Medicine and Drug Development 3 (3), 189-195, 2018 | 3 | 2018 |
| TLR9 signalling inhibits Plasmodium liver infection by macrophage activation M Kordes, L Ormond, S Rausch, K Matuschewski, JCR Hafalla European journal of immunology 52 (2), 270-284, 2022 | 2 | 2022 |
| Risk of developing pancreatic cancer in patients with chronic pancreatitis M Vujasinovic, A Dugic, P Maisonneuve, A Aljic, R Berggren, N Panic, ... Pancreatology 21, S38, 2021 | 2 | 2021 |
| Discordant Reporting of a Previously Undescribed Pathogenic Germline BRCA2 Variant in Blood and Tumor Tissue in a Patient With Pancreatic Adenocarcinoma M Kordes, D Tamborero, K Lagerstedt-Robinson, J Yachnin, ... JCO precision oncology 5, 974-980, 2021 | 1 | 2021 |
| Applying evidence-based software for NGS in pancreatic cancer: First results from the PePaCaKa study. M Loehr, M Kordes, L Malgerud, S Kaduthanam, JE Frödin, M Karimi, ... Journal of Clinical Oncology 36 (15_suppl), e16214-e16214, 2018 | 1 | 2018 |
